"Bezogen auf das Einzugsgebiet ist unsere Klinik im Bereich der Augenheilkunde die größte Primärklinik Österreichs. Die Erkennung, Behandlung und Vorbeugung von Erkrankungen des Auges stehen im Zentrum unserer Arbeit und zwar sowohl im Rahmen der Patientenbetreuung als auch hinsichtlich unseres universitären Auftrags. Alle Versorgungs- und Forschungsschwerpunkte entsprechen dabei höchstem internationalen Niveau. Zu unseren universitären Aufgaben zählen neben der wissenschaftlichen Forschung und forschungsgeleiteten Lehre auch die strukturierte und international zertifizierte Ausbildung von Fachärzt*innen."

During the past decade, LKH-Univ.Klinikum Graz; Universitäts-Augenklinik conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "LKH-Univ.Klinikum Graz; Universitäts-Augenklinik" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "LKH-Univ.Klinikum Graz; Universitäts-Augenklinik" are "Diabetic Macular Edema" (2 trials), "Macular Edema" (2 trials), "Branch Retinal Vein Occlusion" (1 trials), "Central Retinal Vein Occlusion" (1 trials) and "Hemiretinal Vein Occlusion" (1 trials). Many other conditions were trialed in "LKH-Univ.Klinikum Graz; Universitäts-Augenklinik" in a lesser frequency.

Most popular intervention types in "LKH-Univ.Klinikum Graz; Universitäts-Augenklinik" are "Drug" (7 trials), "Procedure" (4 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (6 trials), "Sham Procedure" (6 trials), "Aflibercept" (4 trials), "Port Delivery System with Ranibizumab" (1 trials) and "Ranibizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "LKH-Univ.Klinikum Graz; Universitäts-Augenklinik" are 7 trials for "All" genders.

Currently, there are NaN active trials in "LKH-Univ.Klinikum Graz; Universitäts-Augenklinik". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in LKH-Univ.Klinikum Graz; Universitäts-Augenklinik, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in LKH-Univ.Klinikum Graz; Universitäts-Augenklinik, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".